Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




AI Tool Improves Breast Cancer Detection

By LabMedica International staff writers
Posted on 03 Dec 2025

Breast cancer diagnosis relies on examining microscopic tissue samples, a time-intensive process made more challenging by global shortages of trained pathologists. More...

Delays in diagnosis can lead to missed early treatment opportunities. Now, a new artificial intelligence (AI) system can help interpret tissue slides more quickly and accurately, potentially improving access to timely cancer diagnosis.

The AI system, called the Context-Guided Segmentation Network (CGS-Net), has been designed by researchers at the University of Maine (Orono, ME, USA) to mimic how human pathologists study cancer tissue by combining high-resolution cellular details with broader tissue context. This dual-encoder approach enables the model to interpret histological slides with greater precision than conventional single-input AI systems.

CGS-Net processes two synchronized image patches at once: one captures cell-level structure, while the other offers a wider, lower-resolution view that reflects the tissue architecture surrounding the same pixel. These complementary data streams are merged through interconnected encoders and decoders to create a more holistic analysis of breast cancer features.

The team trained the system on 383 digitized whole-slide lymph node images to distinguish between healthy and cancerous tissue. The findings, published in Scientific Reports, show that CGS-Net consistently outperformed traditional models, demonstrating stronger predictive accuracy for binary cancer segmentation. By reflecting the natural workflow of human pathologists, the tool enhances diagnostic interpretation rather than replacing clinical expertise.

The researchers say the system could expand to include multiple magnification levels, multiclass segmentation, and other cancer types. They also envision integrating radiology or molecular data to support even more comprehensive diagnostic insights. As digital pathology becomes increasingly common, AI systems modeled on real clinical behavior may help bridge diagnostic gaps, particularly in regions facing severe workforce shortages.

“This model integrates both detailed local tissue regions and broader contextual regions to improve the accuracy of cancer predictions in histological slides,” said Jeremy Juybari, who spearheaded the research. “By introducing a unique training algorithm and an innovative initialization strategy, this research demonstrates how incorporating surrounding tissue context can significantly enhance model performance. These findings reinforce the importance of holistic image analysis in medical AI applications.”

Related Link
University of Maine


Gold Member
Fibrinolysis Assay
HemosIL Fibrinolysis Assay Panel
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Automatic CLIA Analyzer
Shine i9000
Sample Transportation System
Tempus1800 Necto
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.